3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Neoplasms
5
Breast Neoplasms
3
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
2
Cardiovascular Diseases
2
Triple Negative Breast Neoplasms
1
Prostatic Intraepithelial Neoplasia
1
Osteoporosis
1
Neuralgia
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Fatigue
1
Eye Diseases
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Breast Neoplasms, Male
1
Bone Diseases, Metabolic
1
Interventions
Aspirin
4
Blood Pressure
3
Vitamin E
2
Vitamin D
2
Nutrition Assessment
2
Metformin
2
Geritol
2
Diet, Mediterranean
2
Cholecalciferol
2
phosphoribosylformylglycinamidine synthetase
1
glycidol
1
ficlatuzumab
1
beta Carotene
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Vorinostat
1
Vascular Stiffness
1
Tumor Necrosis Factor Inhibitors
1
Therapeutics
1
Sugars
1
Spironolactone
1
Resistance Training
1
Raloxifene Hydrochloride
1
Pulse Wave Analysis
1
Progestins
1
Physical Conditioning, Human
1
Omeprazole
1
Noninvasive Prenatal Testing
1
Naproxen
1
Methods
1
Lysine Acetyltransferase 5
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Cardiovascular Diseases
×
Geritol
×
Clear all
NCT02422745
2025-09-24
COSMOS
Brigham and Women's Hospital
Phase 4
Completed
21,442 enrolled
31 charts
NCT00270647
2018-02-28
PHS II
Brigham and Women's Hospital
Phase NA
Completed
14,641 enrolled